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Abstract
Background and Objectives
A previous study reported finding that epilepsy risk is elevated following bariatric surgery for
weight loss; however, this association has not been adequately explored. Our objectives were to
(1) estimate the risk of epilepsy following bariatric surgery for weight loss relative to a nonsurgical cohort of patients with an obesity diagnosis, and (2) identify epilepsy risk factors among
bariatric surgery recipients.

Methods
We conducted a population-based retrospective cohort study using linked health administrative
databases in Ontario, Canada. Participants were accrued between July 1, 2010, and December 31,
2016, and followed until December 31, 2019. All Ontario residents 18 years of age and older
who had bariatric surgery during the accrual period were eligible for inclusion in our exposed
cohort. Patients hospitalized with a diagnosis of obesity and who did not have bariatric surgery
during the accrual period were eligible for inclusion in our unexposed cohort. We excluded
patients with a history of seizures, epilepsy, various seizure or epilepsy risk factors, psychiatric
disorders, or drug or alcohol abuse/dependence. In our primary analysis, we used inverse
probability of treatment weighting to control for confounding. A marginal Cox proportional
hazards model was then used to estimate the risk of epilepsy associated with bariatric surgery. A
Cox model was also used to identify epilepsy risk factors among exposed participants.

Results
The final sample included 16,958 exposed participants and 622,514 unexposed participants.
Following inverse probability of treatment weighting, the estimated rates of epilepsy were 50.1
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and 34.1 per 100,000 person-years among those who did and did not have bariatric surgery,
respectively. The hazard ratio for developing epilepsy after bariatric surgery was 1.45 (95%
CI=1.35, 1.56). Among participants who received bariatric surgery, stroke during follow-up
increased epilepsy risk (HR=14.03, 95% CI=4.26, 46.25).

Discussion
In this study, we found that patients with a history of bariatric surgery were at increased risk of
developing epilepsy. These findings suggest that epilepsy is a long-term risk associated with
bariatric surgery for weight loss.
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Introduction
The global prevalence of obesity in adults has been increasing in recent decades.1 In 1975, it was
estimated to affect 6.6% of women and 3.0% of men. As of 2016, these estimates had increased
to 15.7% and 11.6%, respectively. Those who are obese have an increased risk of many chronic
diseases, including type 2 diabetes mellitus, congestive heart failure, asthma, and osteoarthritis,2
as well as higher all-cause mortality3 and impaired health-related quality of life.4 Bariatric
surgery is more effective than non-surgical treatment at reducing body mass index (BMI) and
inducing the remission of obesity-related chronic diseases.5 As such, bariatric procedures are
being increasingly performed globally.6
Some factors are known to increase epilepsy risk; however, 44-69% of epilepsy cases have no
known cause,7 suggesting that there are epilepsy risk factors that have not yet been identified. In
addition to the positive outcomes of bariatric surgery, several long-term neurological
complications have also been identified.8 Importantly, one study has reported that epilepsy risk is
elevated following Roux-en-Y gastric bypass.9 These findings suggest that bariatric surgery may
be an unrecognized epilepsy risk factor; however, this possible association has not been
thoroughly explored. Thus, our primary objective was to assess whether epilepsy risk is elevated
following bariatric surgery for weight loss relative to a non-surgical cohort of patients who are
obese. Our secondary objective was to identify risk factors associated with epilepsy among
bariatric surgery recipients.

Methods
Study Design and Data Sources
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We answered our research questions using a population-based, retrospective cohort study design,
analyzing individually-linked health administrative data collected on the services provided in the
publicly-funded healthcare system of Ontario, Canada. With an estimated 14.7 million residents
in 2020, Ontario is Canada’s most populous province.10 These datasets were linked using unique,
encoded identifiers and analyzed at ICES.
The databases used in the present study include the Canadian Institute for Health Information
(CIHI) Discharge Abstract Database (DAD), CIHI Same Day Surgery (SDS), CIHI National
Ambulatory Care Reporting System (NACRS), Ontario Health Insurance Plan (OHIP), Ontario
Mental Health Reporting System (OMHRS), Canadian Census, Registered Persons Database
(RPDB), Ontario Marginalization Index (ON-Marg), Ontario Hypertension Dataset (HYPER),
Ontario Cancer Registry (OCR), and the Ontario Diabetes Dataset (ODD). Descriptions of these
datasets can be found in eTable 1 in the Supplement.

Standard Protocol Approvals, Registrations, and Patient Consents
The use of data in this project was authorized under section 45 of Ontario’s Personal Health
Information Protection Act, which does not require individual patient consent nor review by a
Research Ethics Board.

Study Population
We included in our exposed cohort Ontario residents who had a bariatric surgery identified in the
DAD, SDS, or OHIP databases during the accrual period of July 1, 2010, to December 31, 2016.
We included in our unexposed cohort patients who were hospitalized with a diagnosis of obesity
at any point during the accrual period and were Ontario residents as of July 1, 2010. We used the
date of bariatric surgery as the index date for those in the exposed cohort. We randomly assigned
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index dates for those in the unexposed cohort that followed the distribution of index dates in the
exposed cohort. After data cleaning exclusions, we excluded patients from both cohorts who
were younger than 18 or older than 105 years of age. Some patients were included in both the
exposed and the unexposed cohorts because they were hospitalized with obesity and also had
bariatric surgery during the accrual period. Therefore, patients in both the exposed and
unexposed cohorts were excluded from the unexposed cohort. We restricted our analysis to the
last bariatric surgery as the index surgery for patients in the exposed cohort with multiple surgery
dates during the accrual period.
We further excluded those who had evidence of seizures or epilepsy within the ten years prior to
their index date. We also excluded those who had a history of seizure or epilepsy risk factors,
including brain tumours within the ten years prior to index, as well as infections of the central
nervous system, traumatic brain injuries, strokes, paraneoplastic syndromes, or cancer within the
five years prior to index.7,11–15 We also excluded those who had brain surgery within the five
years prior to index, as it indicates an underlying pathology that may increase epilepsy risk.11
Finally, those who receive bariatric surgery in Ontario must be free of drug or alcohol abuse or
dependence, as well as untreated or undertreated psychiatric illness for at least six months prior
to their surgery.16 Therefore, we excluded patients from our study population who had a
healthcare encounter for an anxiety or mood disorder, schizophrenia, or drug or alcohol
abuse/dependence within the six months prior to index. A flow diagram depicting the builds of
our cohorts can be found in Figures 1 and 2. A complete list of the ICD-9, ICD-10, Canadian
Classification of Health Interventions (CCI), and OHIP codes used to define our inclusion and
exclusion criteria can be found in eTable 2 in the Supplement.

Variable Definitions
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Exposure
We used CCI codes in the DAD and SDS databases and OHIP physician billing codes in the
OHIP database to identify those who had bariatric surgery during the accrual period. Many
participants in our exposed cohort had multiple dates recorded for their bariatric procedure since
the date of surgery often differed between the DAD/SDS and OHIP databases. In these cases, we
retained the later date for use as the patients’ index date. Roux-en-Y gastric bypass (also called
“gastric bypass”), and sleeve gastrectomy when gastric bypass is contraindicated, are the
bariatric surgery procedure types that are eligible for funding from OHIP.17 These OHIP codes
are only used for the reimbursement of surgical procedures for which the intent is to induce
weight loss in those with a BMI greater than 40 or with a BMI greater than 35 and one or more
of the following comorbidities: coronary heart disease, diabetes mellitus, clinically significant
obstructive sleep apnea, or medically refractory hypertension.17 However, given that we also
used CCI codes in the DAD/SDS, we also captured procedures performed in public hospitals that
OHIP does not fund, including sleeve gastrectomy (when gastric bypass is not contraindicated),
vertical and adjustable banding, stapling, plication, or a combination of these techniques. The
specific codes we used to identify these procedures can be found in eTable 2 in the Supplement.

Patient Characteristics
We collected data on the patients’ sociodemographic characteristics at their index date, including
age, sex, neighbourhood household income, Ontario Marginalization Index, and Rurality Index
for Ontario score. In the two years prior to index, we also measured the Charlson Comorbidity
Index and several specific comorbidities, including diabetes mellitus, hypertension, sleep apnea,
depression or anxiety, dyslipidemia, acute myocardial infarction, acute coronary syndrome, atrial
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fibrillation, coronary artery disease or ischemic heart disease, and healthcare related to a suicide
attempt. We also included stroke as a time-varying covariate. The specific ICD-10, CCI, and
OHIP codes used to define these covariates can be found in eTable 2 in the Supplement.
In our analysis to identify risk factors for epilepsy among those who received bariatric surgery,
we also included the type of bariatric procedure performed, categorized as sleeve gastrectomy,
gastric bypass, or other, as well as the duration of hospital stay following surgery. The specific
codes used to categorize the bariatric procedures by type can be found in eTable 3 in the
Supplement.

Outcome
We used a validated algorithm of ICD-10 and OHIP physician billing codes to identify patients
who developed epilepsy by December 31, 2019 (eTable 2 in the Supplement).18 The algorithm
identifies patients with epilepsy when they have had three physician billings at least 30 days
apart with a diagnosis of seizures or epilepsy within two years or were hospitalized at least once
for a seizure. The sensitivity of this algorithm was estimated at 73.7% (95% CI=64.8%, 82.5%)
and specificity at 99.8% (95% CI=99.6%, 99.9%).

Statistical Analysis
In our analysis to address our primary objective, we used inverse probability of treatment
weighting (IPTW) to control for confounding. We calculated the propensity score by regressing
patients’ exposure status onto their baseline characteristics using a multivariable logistic
regression model. We included all baseline covariates in our propensity score model except for
sleep apnea, as it was rarely observed in the unexposed cohort. These covariates included age,
sex, neighbourhood household income quintile, the dimensions of the Ontario Marginalization
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Index, Rurality Index for Ontario score, duration of hospital stay, Charlson Comorbidity Index,
diabetes, hypertension, healthcare related to sleep apnea, dyslipidemia, acute myocardial
infarction, acute coronary syndrome, coronary artery disease or ischemic heart disease, and atrial
fibrillation. As very high weights can bias effect estimates when using IPTW,19 we tabulated the
percentage of patients with weights greater than ten. We assessed the effectiveness of our
propensity score model by calculating the weighted standardized differences in baseline
covariates between exposure groups and considering differences greater than 0.1 significant. We
then used a marginal Cox proportional hazards regression model to estimate the hazard ratio
(HR) and its associated 95% CI for developing epilepsy associated with exposure using the
IPTW-weighted exposure groups, controlling for sleep apnea, and including stroke as a timevarying covariate.
Within the cohort that had bariatric surgery, we assessed baseline differences between outcome
groups using standardized differences, considering those greater than 0.1 significant. In
multivariable analysis, we used a Cox proportional hazards regression model to assess whether
baseline characteristics were associated with the outcome among those who had bariatric surgery
and again including stroke as a time-varying covariate. We excluded several covariates from the
multivariable model given the small number of epilepsy diagnoses observed. Since we included
marginalization, rurality, and neighbourhood household income in the analysis to address our
primary objective for similar reasons, we retained only neighbourhood household income for
inclusion in the multivariable model used to address our secondary objective. We excluded
duration of hospital stay (included as a proxy for short-term surgery complications) from the
multivariable model, as we did not expect it to significantly affect long-term outcomes. We also
excluded the Charlson Comorbidity Index, hypertension, sleep apnea, healthcare related to
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suicide attempts, dyslipidemia, acute myocardial infarction, acute coronary syndrome, coronary
artery disease or ischemic heart disease, and atrial fibrillation. The inclusion of stroke as a timevarying covariate likely controlled for at least some of the effect these comorbidity-related
variables may have had on epilepsy risk. The data type and category groupings used in each
analysis can be found in eTable 4 in the Supplement. LR conducted the analyses using SAS
version 9.4 (SAS Institute, Cary, NC) software.

Data Availability
The data used in this study is held securely at ICES. While data sharing agreements prohibit
ICES from making the dataset publicly available, confidential access can be granted to those
who meet pre-specified criteria, available at www.ices.on.ca/DAS. The full data set creation plan
and underlying analytic code are available from the authors upon request, understanding that the
programs may rely upon coding templates or macros that are unique to ICES and are therefore
either inaccessible or may require modification.

Results
We included 639,472 participants, 16,958 (2.7%) of whom had received bariatric surgery. Before
weighting, 73 (0.4%) participants in the exposed cohort and 1,260 (0.2%) participants in the
unexposed cohort developed epilepsy by the end of follow-up. There were no significant
differences between exposure groups in baseline covariates following weighting except for sleep
apnea (Table 1). Patients with IPTW weights greater than ten composed 2.3% of the study
population. In the weighted cohorts, we observed 50.1 epilepsy diagnoses per 100,000 person-
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years (n=1,850) among the exposed and 34.1 per 100,000 person-years among the unexposed
(n=1,304), for a rate difference of 16.0 per 100,000 person-years. Total and median [IQR]
follow-up was 3,691,411 and 5.8 [4.2, 7.5] person-years in the exposed cohort and 3,818,669 and
5.9 [4.3, 7.6] person-years in the unexposed cohort. In the multivariable analysis of the weighted
cohort, we estimated the HR for epilepsy associated with bariatric surgery as 1.45 (95% CI=1.35,
1.56), adjusting for sleep apnea and including stroke as a time-varying covariate.
Given that the analysis for our secondary objective involved only the unweighted exposed
cohort, we observed outcome event rates that differed from those we estimated in addressing our
primary objective. We followed the exposed cohort for a total of 101,890 person-years, over
which we observed 73 epilepsy diagnoses (71.6 per 100,000 person-years). In the bivariate
analysis of the exposed cohort, we observed several significant differences between outcome
groups (eTable 5 in the Supplement). In multivariable analysis, those in neighbourhood
household income quintile 3 had an HR for epilepsy of 0.42 (95% CI=0.20, 0.87) relative to
those in quintile 1 (lowest), and those who had a stroke during follow-up had an HR for epilepsy
of 14.03 (95% CI=4.26, 46.25) relative to those who did not (Table 2).

Discussion
In this study, we estimated that epilepsy risk was significantly higher among those who received
bariatric surgery relative to a control cohort with obesity. In our analysis to identify risk factors
for epilepsy within the exposed cohort, we estimated that those in neighbourhood household
income quintile 3 were at significantly lower epilepsy risk relative to those in quintile 1 (lowest)
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and that those who had a stroke over follow-up were at significantly higher epilepsy risk relative
to those who did not experience a stroke.
Our findings are consistent with those of Marsk et al.,9 who found an increased risk of epilepsy
among those who received Roux-en-Y gastric bypass relative to a sample of the general
population. We showed that this association is apparent even after controlling for important
potential confounders, such as baseline epilepsy risk factors and strokes that occur over followup, including bariatric procedures in addition to Roux-en-Y gastric bypass, and using a more
comparable unexposed group than the general population. As expected, the effect measure was
attenuated relative to the HR of 3.0 (95% CI=2.1, 4.3) reported by Marsk et al.9
Late neurological complications of bariatric surgery, generally defined as occurring 3-20 months
after surgery, have been estimated to occur in 5-16% of patients.8 These complications include
Wernicke–Korsakoff syndrome, acute post-gastric reduction surgery (APGARS) neuropathy,
posterolateral myelopathy, mononeuropathies, polyneuropathies, and acute
polyradiculoneuropathies.8 Our findings suggest that epilepsy may be among these long-term
neurological complications; however, the mechanism remains unclear.
Bariatric surgery induces weight loss through restrictive or malabsorptive mechanisms of
limiting the intake of macronutrients.20 However, the malabsorption of micronutrients often also
occurs, leading to nutritional deficiencies.20 Neurological complications have been primarily
attributed to these deficiencies,20,21 indicating that epilepsy risk may be affected through a similar
mechanism. Although limited, some research investigating the role of micronutrient deficiencies
in epilepsy exists. One study observed significantly lower vitamin C, zinc, and copper levels
among patients with epilepsy and no history of antiepileptic drug treatment relative to healthy
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controls.22 Another study of a small number of patients with epilepsy found that normalizing
serum 25-hydroxy-vitamin D levels significantly reduced median seizure frequency by 40%.23
Alternatively, the increased risk of epilepsy that we observed may be a result of a feature of
surgical intervention that is not specific to bariatric surgery, such as the receipt of general
anesthesia. However, we found limited evidence supporting such an alternative explanation. Few
studies were identified that assessed epilepsy risk following any type of surgery, all of which
were in pediatric populations receiving organ transplants.24–27 One study was identified that
assessed the effect of general anesthesia on the risk of epilepsy relative to neuraxial anesthesia
and reported that epilepsy risk was elevated among those who had general anesthesia.28 Future
research should continue to explore the effect of surgical intervention on the risk of epilepsy, as
this information may suggest whether the elevated risk observed in this study could be
attributable to surgical intervention in general instead of bariatric surgery specifically.
We analyzed the cohort that had bariatric surgery to identify, potentially among other risk
factors, procedure types that further increased epilepsy risk. Gastric bypass is the procedure type
that is most likely to increase the risk of nutritional deficiencies following bariatric surgery, as it
is the most malabsorptive of the commonly performed procedures.20 Therefore, we hypothesized
that epilepsy risk would be higher among those who received gastric bypass than among those
who received other types of bariatric procedures. We did not find that patients were at
differential epilepsy risk as a function of the type of procedure received. However, we likely had
insufficient power to detect differences in risk between the procedure types, given that of those
who developed epilepsy, fewer than six had a sleeve gastrectomy, and fewer than six had a
procedure classified as “other.”
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We identified that those in the middle income quintile were at significantly lower epilepsy risk
than those in the lowest income quintile. Given that we did not observe a gradient among the
quintiles, this result may be the effect of residual confounding. We also identified stroke over
follow-up as a significant risk factor for new-onset epilepsy. This result is less likely to be
entirely due to residual confounding, considering its large magnitude of effect (HR=14.03), and
that stroke is a well-known epilepsy risk factor.29 However, the very wide confidence interval
around this estimate (95% CI=4.26, 46.25) indicates that we observed a small number of strokes.
Future research should seek to provide a more precise estimate of the effect of stroke occurring
after bariatric surgery on epilepsy risk.
This study has some limitations. As with all studies that use health administrative data to define
their variables, misclassification may have occurred. The degree of misclassification of our
outcome is approximately known, as the algorithm that we used was validated, demonstrating
high predictive values (PPV=79.5%, 95% CI=71.1%, 88.0%; NPV=99.7%, 95% CI=99.5%,
99.8%).18
The degree of misclassification of our exposure is less precisely known; however, we expect it to
be minimal. Physicians in Ontario are not permitted to bill residents insured by OHIP for an
OHIP-insured service or procedure under the Commitment to the Future of Medicare Act.30
Therefore, all gastric bypass procedures performed during our accrual period on persons eligible
for inclusion in our unexposed cohort are very likely to have been captured. We also would have
captured bariatric procedures of any type performed in public hospitals required to report clinical
data to CIHI for indexing in the DAD and SDS. However, we would not have captured bariatric
procedures that are not eligible for funding from OHIP and were performed in facilities that are
not required to report data to CIHI. Though Ontario-specific estimates are unavailable, an
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estimated 1,000 bariatric procedures were performed in private clinics in all of Canada in 2012
relative to the almost 6,000 performed in public hospitals across the country in the same year.31
Medical tourism to other provinces and countries for bariatric surgery by Canadians also occurs;
however, estimates of its frequency are unavailable.32 As a final consideration, the proportion of
bariatric procedures that were not captured by the databases used in this study likely decreased
over follow-up, as access to publicly-funded bariatric surgery in Ontario increased substantially
beginning in 2009.31 Importantly, the net effect of these potential sources of exposure
misclassification would bias our effect estimate toward the null hypothesis.
We used a diagnosis of obesity identified in the DAD, an inpatient hospitalization database, as
our criterion for inclusion in our unexposed cohort because we could not obtain BMI data for
IPTW. This may have affected our findings, as those hospitalized with a diagnosis of obesity
may systematically differ from those who received bariatric surgery in a way that may affect
epilepsy risk. However, we addressed this source of potential confounding by controlling for the
most common obesity-related comorbidities prevalent at baseline.
We were also unable to measure obesity status or BMI over follow-up. This is an important
consideration because some obesity-related comorbidities may affect epilepsy risk. Stroke is
likely the most significant source of time-dependent confounding in studies seeking to address
this research question, as obesity increases stroke risk33 and stroke is a known cause of
epilepsy.29 Therefore, we included stroke as a time-varying covariate to account for the most
significant source of time-dependent confounding. Obesity itself and obesity-related
comorbidities other than stroke are generally not considered established epilepsy risk factors.7
It remains possible that differences in the prevalence of sleep apnea between the exposed and
unexposed cohorts were not sufficiently controlled in the multivariable analysis, despite the
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inclusion of this variable in the Cox regression model. Sleep apnea was only observed in 1.2% of
the weighted unexposed cohort and 30.8% of the weighted exposed cohort. This likely reflects
underdiagnosis of the disorder in the unexposed cohort, as a sleep apnea diagnosis would qualify
a patient with a BMI between 35 and 40 for bariatric surgery. We could identify only one study
in the literature that estimated the effect of sleep apnea on the risk of new-onset epilepsy, and the
authors reported that epilepsy risk was significantly higher among patients with sleep apnea than
those without sleep apnea.34 Therefore, it is unclear whether the imbalance in the prevalence of
sleep apnea between our exposed and unexposed cohorts biased our effect estimate.
The generalizability of our findings is likely to be most significantly affected by the differences
in the distribution of bariatric procedure types performed between regions globally.6 If
nutritional deficiencies are the mechanism driving the observed association, the distribution of
the procedure types performed will affect the strength of the association between bariatric
surgery and new-onset epilepsy.

Conclusion
Bariatric surgery is an effective treatment for obesity and obesity-related chronic conditions.5
However, this research supports a previous finding that bariatric surgery recipients have an
elevated risk of epilepsy. Future research should continue to investigate epilepsy as a potential
long-term complication of bariatric surgery, exploring the possible modifying effect of procedure
type.
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Table 1. Unadjusted baseline patient characteristics of weighted study sample by exposure status.
Weighted
Had bariatric
Did not have
standardized
surgery
bariatric surgery
differencea
Total, N (%)
624,801 (49.4%)
639,494 (50.6%)
Demographics
Age, Mean (SD)
47.41 ± 69.33
47.59 ± 15.27
0.04
Male, N (%)
218,097 (34.9%)
238,124 (37.2%)
0.05
Neighbourhood household income quintile,
N (%)b
Quintile 1-2, Missing
262,255 (42.0%)
257,998 (40.3%)
0.02
Quintile 3-5
362,547 (58.0%)
381,496 (59.7%)
0.02
Ontario Marginalization Index score, N (%)c
Ethnic concentration
Quintile 1-2, Missing
195,512 (31.3%)
195,602 (30.6%)
0.01
Quintile 3-5
429,289 (68.7%)
443,892 (69.4%)
0.01
Material deprivation
Quintile 1-2, Missing
230,866 (37.0%)
239,033 (37.4%)
0.01
Quintile 3-5
393,935 (63.0%)
400,461 (62.6%)
0.01
Dependency
Quintile 1-2, Missing
291,362 (46.6%)
298,784 (46.7%)
0
Quintile 3-5
333,439 (53.4%)
340,710 (53.3%)
0
Residential instability
Quintile 1-2, Missing
250,981 (40.2%)
263,499 (41.2%)
0.01
Quintile 3-5
373,820 (59.8%)
375,995 (58.8%)
0.01
Rurality Index for Ontario score, N (%)d
0-45 (urban), Missing
600,262 (96.1%)
617,270 (96.5%)
0.02
46+ (rural)
24,539 (3.9%)
22,224 (3.5%)
0.02
Surgery-related
Duration of hospital stay (Days)
Mean (SD)
3.16 ± 8.66
N/A
N/A
Median (IQR)
2 (2-2)
N/A
N/A
Comorbidities, N (%)
Charlson Comorbidity Index
0 or no hospitalizationse
579,031 (92.7%)
607,312 (95.0%)
0.07
1+
45,770 (7.3%)
32,182 (5.0%)
0.07
Diabetes
119,661 (19.2%)
118,569 (18.5%)
0.01
Hypertension
215,843 (34.5%)
232,224 (36.3%)
0.03
Healthcare related sleep apnea
192,290 (30.8%)
7,569 (1.2%)
0.63
Depression or anxiety
52,834 (8.5%)
46,862 (7.3%)
0.03
Healthcare related to suicide attempt
1,085 (0.2%)
992 (0.2%)
0
Dyslipidemia
77,973 (12.5%)
89,941 (14.1%)
0.03
Acute myocardial infarction
9,566 (1.5%)
5,635 (0.9%)
0.04
Acute coronary syndrome
51,311 (8.2%)
43,017 (6.7%)
0.04
Coronary artery disease or ischemic heart
14,548 (2.3%)
11,003 (1.7%)
0.03
disease
Atrial fibrillation
6,743 (1.1%)
5,179 (0.8%)
0.02
a
Weighted standardized differences greater than 0.1 were considered significant.
b
The weighted number of missing individuals is 1,601 (0.3%) in the exposed cohort and 1,491 (0.2%) in the
unexposed cohort.
c
The weighted number of missing individuals is 7,775 (1.2%) in the exposed cohort and 5,841 (0.9%) in the
unexposed cohort.
d
The weighted number of missing individuals is 266,957 (42.7%) in the exposed cohort and 290,366 (45.4%) in
the unexposed cohort.
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“no hospitalizations” includes patients with zero hospitalizations during the previous two years, “0” includes
patients who had one or more hospitalizations during this period, but none for any of the conditions that are included
in the Charlson Comorbidity Index
e
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Table 2. The results of the adjusted Cox proportional hazards regression for the association between
selected covariates and new-onset epilepsy among those who had bariatric surgery.
HR
95% CI
Age
0.99
0.96-1.01
Male
1.04
0.52-1.77
Neighbourhood household income
Quintile 1
1.0 (reference)
Quintile 2
0.61
0.33-1.13
Quintile 3
0.42
0.20-0.87
Quintile 4
0.56
0.28-1.11
Quintile 5
0.68
0.34-1.38
Missing
0
0-0
Bariatric procedure
Other
1.0 (reference)
Sleeve gastrectomy
0.43
0.05-3.85
Gastric bypass
1.13
0.16-8.23
Diabetes
0.92
0.56-1.51
Depression or anxiety
1.68
0.97-2.92
Stroke during follow-up
14.03
4.26-46.25
HR = hazard ratio; CI = confidence interval
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Figure Titles
Figure 1. Flow diagram depicting the build of the exposed cohort.
Figure 2. Flow diagram depicting the build of the unexposed cohort.

